A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances

Angiogenesis

Volumn 6, Issue 3, 2003, Pages 251-254

  González Iriarte, Mauricio ^a   Carmona, Rita ^a   Pérez Pomares, José María ^a   Macías, David ^a   Medina, Miguel Ángel ^a   Quesada, Ana R ^a   Muñoz Chápuli, Ramón ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Aeroplysinin 1; Angiogenesis; Apoptosis; Camptothecin; Chorioallantoic membrane assay; Endothelium; TUNEL assay

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOASSAY; CELL NUCLEUS; CHORIOALLANTOIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COTURNIX; EMBRYO; ENDOTHELIUM CELL; GROWTH INHIBITION; IN VIVO STUDY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; QUAIL; STEM CELL;

ACETONITRILES; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL NUCLEUS; CHORIOALLANTOIC MEMBRANE; CYCLOHEXENES; ENDOTHELIUM, VASCULAR; IN SITU NICK-END LABELING; METHODS; MICROSCOPY, CONFOCAL; PROPIDIUM; QUAIL; STAINING AND LABELING;

ANIMALIA; COTURNIX; COTURNIX COTURNIX; COTURNIX JAPONICA; JAPONICA; PHASIANIDAE;

EID: 11144355632     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:AGEN.0000021388.59617.6b     Document Type: Article

References (17)

1. Folkman J. Angiogenesis in cancer, vascular rheumatoid and other disease. Nat Med 1995; 1: 27-31.
2. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nature Rev Cancer 2002; 2: 727-39.
3. Jain RK, Schlenger K, Höckel M, Yuan F. Quantitative angiogenesis assays: Progress and problems. Nat Med 1997; 3: 1203-8.
4. Auerbach R, Lewis R, Shinners B et al. Angiogenesis assays: A critical overview. Clin Chem 2003; 49: 32-40.
5. Parsons-Wingerter P, Lwai B, Yang MC et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: Stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res 1998; 55: 201-14.
6. Oh SJ, Jeltsch MM, Birkenhager R et al. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997; 188: 96-109.
7. Pardanaud L, Altmann C, Kitos P et al. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 1987; 100: 339-49.
8. Kollmannsberger C, Mross K, Jakob A et al. Topotecan - A novel topoisomerase I inhibitor: Pharmacology and clinical experience. Oncology 1999; 56 (1): 1-12.
9. Kaufmann SH. Cell death induced by topoisomerase-targeted drugs: More questions than answers. Biochim Biophys Acta 1998; 1400: 195-211.
10. Jung LL, Zamboni WC. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: Can we improve it? Drug Resist Update 2001; 4: 273-88.
11. Clements MK, Jones CB, Cumming M, Daoud SS. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 1999; 44: 411-6.
12. Xiao D, Tan W, Li M, Ding J. Antiangiogenic potential of 10-hydroxycamptothecin. Life Sci 2001; 69: 1619-28.
13. Nakashio A, Fujita N, Tsuruo T. Topotecan inhibits VEGF and bFGF induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway. Int J Cancer 2002; 98: 36-41.
14. Rodríguez-Nieto S, González-Iriarte M, Carmona R et al. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J 2002; 16: 261-3.
15. Kreuter MH, Leake RE, Rinaldi F et al. Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1. Comp Biochem Physiol 1990; 97: 151-8.
16. Ribatti D, Urbinati C, Nico B et al. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995; 170: 39-49.
17. Kreuter MH, Bernd A, Holzmann H et al. Cytostatic activity of aeroplysinin-1 against lymphoma and epithelioma cells. Z Naturforsch [C] 1989; 44(7-8): 680-8.